Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB1,38
PKN101,32101,385,40
Msft473,18473,24-2,15
Nokia5,5385,786-0,43
IBM291,05291,14-1,74
Mercedes-Benz Group AG62,0162,033,10
PFE25,1725,181,10
02.01.2026 17:45:43
Indexy online
AD Index online
select
AD Index online
 

  • 23.12.2025 16:25:00
Piraeus Fin Hlg Rg (Athens)
Závěr k 23.12.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
7,01 -0,48 -0,03 44 104 486
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 02.01.2026
Popis společnosti

Business Summary: Piraeus Financial Holdings SA, formerly known as Piraeus Bank SA, is a Greece-based banking institute. It operates in the following main business segments: Retail Banking, Corporate Banking, Investment Banking, as well as Asset Management and Treasury. The Retail Banking segment includes the retail banking operations of the Bank and its subsidiaries, which are addressed to retail customers, as well as to small-medium companies, such as deposits, loans and letters of guarantee, among others. The Corporate Banking segment includes facilities related to corporate banking, provided by the Bank and its subsidiaries, addressed to maritime companies, such as syndicated loans, project financing and imports-exports, among others. The Investment Banking segment includes activities related to investment banking operations of the Bank and its subsidiaries, such as investment and advisory services, underwriting services and public listings, as well as stock exchange services, among others.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Piraeus Financial Holdings SA interest income decreased 35% to EUR2B. Net interest income after loan loss provision decreased 35% to EUR1.28B. Net income decreased 31% to EUR820M. Net interest income after loan loss provision reflects Retail Banking segment decrease of 8% to EUR751M, Corporate Banking segment decrease of 10% to EUR488M.



  • Poslední aktualizace: 02.01.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerJoaquin Duato62
Chief Financial Officer, Executive Vice PresidentJoseph Wolk5801.07.2018
Chief Human Resources Officer, Executive Vice PresidentKristen Mulholland5801.10.202401.10.2024
Executive Vice President, Chief Technology Officer and Risk OfficerKathryn Wengel5902.07.2018
Executive Vice President, Chief Information OfficerJames Swanson5903.01.202201.01.2019
Executive Vice President - Global Corporate AffairsVanessa Broadhurst5601.01.2022
Executive Vice President, Chief Legal OfficerElizabeth Forminard5417.10.202217.10.2022
Executive Vice President - Innovative Medicine, Research and DevelopmentJohn Reed6603.04.202303.04.2023
Executive Vice President, Worldwide Chairman of MedTechTim Schmid5520.10.202320.10.2023
Executive Vice President, Worldwide Chairman, Innovative MedicineJennifer Taubert6102.07.201802.07.2018